Ocular Surface Changes With Topical Prostaglandin Analog Therapy

NCT00798694 Phase 4 COMPLETED Results posted

To determine whether one glaucoma eye drop is less likely to cause changes to the surface of the eye (conjunctiva) than another. The two different prostaglandins are Xalatan and Travatan Z.

Details

Lead sponsor	Wills Eye
Phase	Phase 4
Status	COMPLETED
Enrolment	58
Start date	2008-11
Completion	2011-02

Conditions

• Glaucoma

Interventions

• Xalatan
• Travatan Z

Primary outcomes

• Change in Tear Break up Time (TBUT) — Baseline, 1 month, 2 months
  Difference of tear break up time (in seconds, average of 3 measurements) at one and two months after enrollment.

Countries

United States